NasdaqCM - Delayed Quote USD
Addex Therapeutics Ltd (ADXN)
At close: October 21 at 4:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-7,826.57
-7,992.41
-16,437.19
-14,705.19
-12,180.07
--
Investing Cash Flow
4,665.07
-6.84
2.97
-30.31
-59.41
--
Financing Cash Flow
-140.18
5,264.60
3,102.69
16,402.82
46.40
--
End Cash Position
3,867.40
3,865.48
6,957.09
20,484.84
18,695.04
--
Capital Expenditure
--
-6.84
-0.58
-31.55
-59.41
--
Issuance of Capital Stock
1,190.75
2,350.51
1,675.87
13,958.19
720.01
--
Repayment of Debt
-210.92
-281.79
-288.08
-309.62
-367.41
--
Free Cash Flow
-7,828.45
-7,999.25
-16,437.77
-14,736.73
-12,239.48
--
12/31/2019 - 2/12/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HVE.DU Innoviva Inc
18.10
0.00%
LIPUM.ST Lipum AB (publ)
14.10
-0.70%
CIRCA.OL Circa Group AS
0.6380
0.00%
CRNA.OL Circio Holding ASA
0.6780
+13.76%
ULTI.OL Ultimovacs ASA
1.8200
0.00%
ANTH Anthera Pharmaceuticals, Inc.
0.0001
0.00%
ICUCW SeaStar Medical Holding Corporation
0.0390
-2.50%
DIABIO.ST Diagonal Bio AB (publ)
0.0351
-9.54%
TTNP Titan Pharmaceuticals, Inc.
4.5800
-0.65%
ATORX.ST Alligator Bioscience AB (publ)
1.2100
-4.12%